[1]PASCUAL S, HERRERA I, IRURZUN J.New advances in hepatocellular carcinoma[J].World J Hepatol, 2016, 8 (9) :421-438.
|
[2]KIM JU, SHARIFF MI, CROSSEY MM, et al.Hepatocellular carcinoma:Review of disease and tumor biomarkers[J].World J Hepatol, 2016, 8 (10) :471-484.
|
[3]LLOVET JM, BRU'C, BRUIX J.Prognosis of hepatocellular carcinoma:The BCLC staging classification[J].Semin Liver Dis, 1999, 19 (3) :329-338.
|
[4]WEDD JP, NORDSTROM E, NYDAM T, et al.Hepatocellular carcinoma in patients listed for liver transplantation:Current and future allocation policy and management strategies for the individual patient[J].Liver Transpl, 2015, 21 (12) :1543-1552.
|
[5]MAO YQ, LIANG XM, FU HY, et al.Effects ofβ-elemene onα-tubulin of Human Hepatocarcinoma Hep G-2 Cells[J].China Cancer, 2012, 21 (2) :145-149. (in Chinese) 毛雨秋, 梁鑫淼, 付海雁, 等.β-揽香烯注射液对人肝癌Hep G-2细胞微观蛋白α的影响[J].中国肿瘤, 2012, 21 (2) :145-149.
|
[6]LU LG.Advances in early screening and diagnosis of hepatocellular carcinoma[J].J Clin Hepatol, 2017, 33 (7) :1257-1261. (in Chinese) 陆伦根.原发性肝癌的早期筛查及诊断[J].临床肝胆病杂志, 2017, 33 (7) :1257-1261.
|
[7]VARIS A, SALMELA AL, KALLIO MJ.Cenp-F (mitosin) is more than a mitotic marker[J].Chromosoma, 2006, 115 (4) :288-295.
|
[8]BRENDLE A, BRANDT A, JOHANSSON R, et al.Single nucleotide polymorphisms in chromosomal instability genes and risk and clinical outcome of breast cancer:A Swedish prospective case-control study[J].Eur J Cancer, 2009, 45 (3) :435-442.
|
[9]CHEN WB, CHENG XB, DING W, et al.Centromere protein F and survivin are associated with high risk and a poor prognosis in colorectal gastrointestinal stromal tumours[J].J Clin Pathol, 2011, 64 (9) :751-755.
|
[10]CAO JY, LIU L, CHEN SP, et al.Prognostic significance and therapeutic implications of centromere protein F expression in human nasopharyngeal carcinoma[J].Mol Cancer, 2010, 9:237.
|
[11]ROESSLER S, JIA HL, BUDHU A, et al.A unique metastasis gene signature enables prediction of tumor relapse in early-stage hepatocellular carcinoma patients[J].Cancer Res, 2010, 70 (24) :10202-10212.
|
[12]PFALTZGRAFF ER, ROTH GM, MILLER PM, et al.Loss of CENP-F results in distinct microtubule-related defects without chromosomal abnormalities[J].Mol Biol Cell, 2016, 27 (13) :1990-1999.
|
[13]FRITZLER MJ, RATTNER JB, LUFT LM, et al.Historical perspectives on the discovery and elucidation of autoantibodies to centromere proteins (CENP) and the emerging importance of antibodies to CENPF[J].Autoimmun Rev, 2011, 10 (4) :194-200.
|
[14]LIU SQ, CHEN W, YANG LH.Effect of down-regulation of CENP-F by RNAi on proliferation in human glioma cell line U251[J].Lingnan J Emerg Med, 2015, 20 (5) :391-393. (in Chinese) 刘淑琼, 陈伟, 杨炼红.RNA干扰下调CENP-F对U251细胞增殖的影响[J].岭南急诊医学杂志, 2015, 20 (5) :391-393.
|
[15]ZHOU HB, HU HP.Challenges in precise treatment for primary liver cancer based on gene mutation[J].J Clin Hepatol, 2017, 33 (7) :1209-1210. (in Chinese) 周华邦, 胡和平.基于基因突变的原发性肝癌精准治疗的挑战[J].临床肝胆病杂志, 2017, 33 (7) :1209-1210.
|
[16]LIN SC, KAO CY, LEE HJ, et al.Dysregulation of miRNAsCOUP-TFII-FOXM1-CENPF axis contributes to the metastasis of prostate cancer[J].Nat Commun, 2016, 7:11418.
|
[17]HOLT SV, VERGNOLLE MA, HUSSEIN D, et al.Silencing Cenp-F weakens centromeric cohesion, prevents chromosome alignment and activates the spindle checkpoint[J].J Cell Sci, 2005, 118 (Pt20) :4889-4900.
|
[18]KIM HE, KIM DG, LEE KJ, et al.Frequent amplification of CENPF, GMNN and CDK13 genes in hepatocellular carcinomas[J].PLo S One, 2012, 7 (8) :e43223.
|
[19]ZHUO YJ, XI M, WAN YP, et al.Enhanced expression of centromere protein F predicts clinical progression and prognosis in patients with prostate cancer[J].Int J Mol Med, 2015, 35 (4) :966-972.
|
[20]BROWN HK, OTTEWELL PD, COLEMAN RE, et al.The kinetochore protein Cenp-F is a potential novel target for zoledronic acid in breast cancer cells[J].J Cell Mol Med, 2011, 15 (3) :501-513.
|
[21]MI YJ, GAO J, XIE JD, et al.Prognostic relevance and therapeutic implications of centromere protein F expression in patients with esophageal squamous cell carcinoma[J].Dis Esophagus, 2013, 26 (6) :636-643.
|
[22]ZHU XL, MANCINI MA, CHANG KH, et al.Characterization of a novel 350-kilodalton nuclear phosphoprotein that is specifically involved in mitotic-phase progression[J].Mol Cell Biol, 1995, 15 (9) :5017-5029.
|